Mukesh Nandave - Böcker

Immunity to Immunotherapy in Cancer: Mechanisms and Limitations explores the intricate interplay between cancer therapy and the immune system, addressing why some patients do not respond to immunotherapy and scientific solutions in development. The book examines molecular strategies of immune evasion within the tumor microenvironment, providing insights into factors like tumor heterogeneity and immune checkpoint mechanisms that contribute to resistance. Highlighting promising approaches such as combination therapies, personalized medicine, and novel immunotherapeutic agents, the book aims to enhance patient outcomes and advance cancer immunotherapy.Designed as a comprehensive guide for professionals and researchers, this textbook offers an overview of the latest scientific discoveries and practical applications in cancer therapy. It serves as an invaluable resource for scientists, doctors, academicians, and students, presenting a path toward more effective, non-toxic, and customized cancer treatments. This book is essential for anyone interested in the future of cancer therapy.Provides an in-depth examination of the molecular strategies of immune evasion and the tumor microenvironment, offering critical insights into why some patients do not respond to immunotherapyBridges the gap between current research and practical therapeutic applications in cancer immunotherapyHighlights the latest advancements in cancer therapy, discussing cutting-edge strategies such as combination therapies, personalized medicine, and novel immunotherapeutic agents

This book integrates the latest advancements in biomedical science related to metabolic syndrome and microbiome research. It comprehensively covers a broad range of topics including composition and function of the gut microbiota in metabolic syndrome, mechanisms linking the gut microbiome to metabolic syndrome, dietary interventions, pharmacological approaches, exercise, lifestyle modifications, psychosocial factors, role of the gut microbiome in obesity and insulin resistance, and clinical applications and translational perspectives.  Despite significant research on metabolic syndrome, its risk factors, therapeutic interventions and the role of microbiome, there is still lack of recent updates and massive efforts are required to update the information on these topics with special emphasis on potential interventions targeting the gut microbiome to mitigate metabolic syndrome risk. This book focuses on leveraging the intricate relationship between the microbiome, gut health, and metabolic syndrome, including dysbiosis, inflammation, impaired gut barrier function, mechanisms through which the gut microbiome influences metabolic syndrome including host-microbiota interactions, microbial metabolites, and immune modulation to develop innovative interventions aimed at improving overall health outcomes. The purpose of this research is to explore microbiome-based interventions that can positively influence gut ecology and mitigate the risk factors associated with metabolic syndrome. By understanding how specific dietary interventions, probiotics, prebiotics, and other microbiome-targeted therapies can modulate the gut microbiome, this work aims to develop effective strategies for optimizing gut health and metabolic function.Through interdisciplinary collaboration and cutting-edge research methodologies, this work strives to pave the way for personalized approaches to healthcare that prioritize the microbiome as a key determinant of overall health and well-being. The principal audience for this book comprises of pharmacologists, microbiologists, clinical pharmacists, and toxicologists.

The book explores the world of medicinal plants through a groundbreaking and comprehensive book.

The book explores the world of medicinal plants through a groundbreaking and comprehensive book. It delves into high-throughput technologies and multi-omics approaches to unlock the untapped potential of endophytic fungi, revealing novel bioactive compounds. It further talks about the diverse biodiversity and ethnopharmacological knowledge, unravelling the molecular intricacies of secondary metabolites under varying ecological conditions. This gives insights into medicinal plant research, offering cutting-edge insights into genome-based barcoding, nanotechnology, and functional genomics for revolutionary drug discoveries. From proteomic and epigenomic analysis to big data exploration, this book presents a holistic view of medicinal plants' potential and discusses the latest advancements in micropropagation, agronomical approaches, and genome editing, paving the way for transformative medicines and healthcare breakthroughs.It serves as a great resource for academicians, researchers, and pharmacologists.

This book delves into diverse facets and applications of medicinal plants. It discusses the metabolic, transcriptomic, and genomic intricacies of medicinal plants, shedding light on their chemical compositions, genetic makeup, and regulatory mechanisms. It includes a chapter on nanotechnology, investigating the influence of nanoparticles on medicinal plants. Subsequent chapters explore functional genomics and genome editing, showcasing innovative approaches to modifying plant genetics. It also discusses plant-associated microorganisms in the microbiome and endophytic fungi. Furthermore, the book addresses the critical issues of genetic diversity, agrotechnology for sustainable production, intellectual property rights, and the impact of various stresses on medicinal plants. This book serves as a valuable resource for researchers, educators, and students of pharmacology, offering a comprehensive understanding of medicinal plants and their evolving role in science and medicine.

This book delves into diverse facets and applications of medicinal plants. It discusses the metabolic, transcriptomic, and genomic intricacies of medicinal plants, shedding light on their chemical compositions, genetic makeup, and regulatory mechanisms. It includes a chapter on nanotechnology, investigating the influence of nanoparticles on medicinal plants. Subsequent chapters explore functional genomics and genome editing, showcasing innovative approaches to modifying plant genetics. It also discusses plant-associated microorganisms in the microbiome and endophytic fungi. Furthermore, the book addresses the critical issues of genetic diversity, agrotechnology for sustainable production, intellectual property rights, and the impact of various stresses on medicinal plants. This book serves as a valuable resource for researchers, educators, and students of pharmacology, offering a comprehensive understanding of medicinal plants and their evolving role in science and medicine.

This book is a comprehensive coverage of the ubiquitin-proteasome system and its involvement in cancer progression, and the application of PROTACs in different types of cancer treatment. The book also describes the chemistry and design aspects of PROTACs and their role in various types of cancers.

The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients.

This book delves into the various aspects of the renin-angiotensin-aldosterone system (RAAS) and its role in cardiovascular disorders. It explores the use of anti-hypertensive agents, with a focus on (ACE) angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Additionally, the book examines the role of ACE inhibitors and ARBs in COVID-19 patients and provides insights into recent trends in managing hypertension through RAAS inhibition. It serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in the field of cardiovascular medicine.

The book delves into the development and therapeutic potential of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors for the treatment of diabetes and cardiovascular diseases.

The book explores the field of pharmacovigilance, its historical context, along with its critical role in ensuring the safety of medications across the world.